Depomed to Release First Quarter Financials on May 8 and to Present at 11th Annual JMP Research Conference on May 14
01 mai 2012 06h00 HE
|
Depomed, Inc.
MENLO PARK, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it will release its first quarter financials after the market close on May 8, 2012 and that it will...
Depomed Announces Intent to File NDA for Serada for Treatment of Menopausal Hot Flashes
17 avr. 2012 16h05 HE
|
Depomed, Inc.
MENLO PARK, Calif., April 17, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has completed a Type B pre-NDA meeting with the United States Food and Drug Administration...
Depomed Announces Receipt of $2.5 Million License Fee From Boehringer Ingelheim
28 mars 2012 16h05 HE
|
Depomed, Inc.
MENLO PARK, Calif., March 28, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received the remaining license fee payment resulting from its collaboration with...
Depomed to Present at 24th Annual Roth Growth Stock Conference
12 mars 2012 14h15 HE
|
Depomed, Inc.
MENLO PARK, Calif., March 12, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that James A. Schoeneck, Depomed's President and CEO, will be presenting at the 24th Annual Roth...
Depomed Reports Fourth Quarter and Year-End 2011 Financial Results
08 mars 2012 16h05 HE
|
Depomed, Inc.
MENLO PARK, Calif., March 8, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the fourth quarter and year ended December 31, 2011.
2011 Business...
Depomed Files Patent Infringement Lawsuit Against Gralise(R) ANDA Filers
05 mars 2012 06h30 HE
|
Depomed, Inc.
MENLO PARK, Calif., March 5, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced it has filed a patent infringement lawsuit in the United States District Court for the District of New...
Depomed to Announce Fourth Quarter and Year-End Financial Results on March 8, 2012
01 mars 2012 06h30 HE
|
Depomed, Inc.
MENLO PARK, Calif., March 1, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it will release fourth quarter and year-end financial results after the market closes on Thursday...
Depomed to Present at Citi 2012 Global Healthcare Conference and RBC Capital Markets Healthcare Conference
22 févr. 2012 10h15 HE
|
Depomed, Inc.
MENLO PARK, Calif., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it will be presenting at the Citi 2012 Global Healthcare Conference and the RBC Capital Markets...
Depomed Announces FDA Approval of Merck's JANUMET(R) XR That Accesses Depomed Patents Licensed to Merck
03 févr. 2012 16h15 HE
|
Depomed, Inc.
MENLO PARK, Calif., Feb. 3, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that Merck disclosed on February 2, 2012 that the U.S. Food and Drug Administration (FDA) approved...
Depomed Announces Initiation of Phase 2 Clinical Study in Parkinson's Disease
24 janv. 2012 16h05 HE
|
Depomed, Inc.
MENLO PARK, Calif., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has initiated a Phase 2 clinical trial of DM-1992, Depomed's novel gastric-retentive,...